AstraZeneca: TROPION-Breast01 Phase III Trial Fails To Achieve Statistical Significance
Datopotamab deruxtecan is a TROP2-directed DXd ADC engineered by Daiichi Sankyo and co-developed by AstraZeneca and Daiichi Sankyo. The data pertaining to this compound will be presented at an ...
Apollo Reportedly To Invest Up To $5 Bln In Intel
(RTTNews) - Private equity firm Apollo Global Management Inc. (APO) has offered to make as much as $5 billion investment in chipmaker Intel Corp., Bloomberg reported citing people familiar with the ...
REA Group Announces Further Increased Possible Offer For Rightmove - Quick Facts
REA Group said, on 22 September 2024, it made a further increased possible cash and share offer for the entire issued and to be issued share capital of Rightmove under which, shareholders of Rightmove ...
European Shares Seen Up As China Announces Another Rate Cut
(RTTNews) - European stocks may open broadly higher on Monday after the People's Bank of China cut the 14-day reverse repurchase interest rate by 10 basis points to 1.85 percent as part of reductions ...
What's Behind The 10% Fall In Southwest Airlines Stock?
Southwest Airlines’ revenue grew from $15.8 billion in 2021 to just $26.1 billion in 2023, driven by a recovery in travel demand post pandemic. Southwest Airlines’ revenue passenger miles (RPM) grew ...
What's Next For FedEx Stock After A Dismal Q1?
FedEx stock (NYSE: FDX) saw a 13% fall in after-market hours on Thursday, September 19, after it reported Q1’25 results (fiscal ends in May) far worse than the street estimates. FDX stock is up 7% ...
Malaysia Bourse May Spin Its Wheels On Monday
(RTTNews) - The Malaysia stock market has climbed higher in back-to-back sessions, gathering almost 10 points or 0.6 percent along the way. The Kuala Lumpur Composite Index now rests just beneath the ...
This Cryptocurrency Could Soar by 23,000% Over the Next 2 Decades, According to MicroStrategy's Michael Saylor
Among them is Michael Saylor, founder and executive chairman of MicroStrategy (NASDAQ: MSTR), who recently doubled down on ...
2 Top Dividend Growth Stocks With Payout Ratios Below 50%
General Dynamics' stock stands out as a top pick thanks to its robust dividend profile. It currently offers a healthy yield ...
Where Will Rivian Stock Be in 1 Year?
Every investor wants to find a diamond in the rough -- that overlooked stock that can deliver multi-bagger returns over the ...
Wedbush Upgrades Zillow Group (BRSE:0ZG)
Fintel reports that on September 16, 2024, Wedbush upgraded their outlook for Zillow Group ( BRSE:0ZG) from Neutral to Outperform. What is the Fund Sentiment?
Is It Too Late to Buy Microsoft Stock Now?
Microsoft (NASDAQ: MSFT) investors have been rewarded handsomely over the past five years with an impressive total return of ...